The clinical use of platelet-rich plasma (PRP) is based on the increase in the concentration of growth factors and in the secretion of proteins which are able to maximize the healing process at the cellular level. Since PRP is an autologous biologic material, it involves a minimum risk of immune reactions and transmission of infectious and contagious diseases, and it has been widely used for the recovery of musculoskeletal lesions. Despite the great potential for applicability, the implementation of the therapeutic employment of PRP as a clinical alternative has become difficult, due to the lack of studies related to the standardization of the techniques and/or insufficient description of the adopted procedures. Therefore, it is required establish standard criteria to be followed for obtaining a PRP of high quality, as well as a larger number of studies which should establish the proper concentration of platelets for the different clinical conditions. In this context, the purpose of this review is to discuss some methodological aspects used for achieving the PRP, as well as to discuss the bioactive properties of PRP, and to point out its therapeutic use in different fields of regenerative medicine.

Peer reviewed article authored by (João Tadeu Ribeiro-Paes, Aldemir Bilaqui, Oswaldo T Greco, et al). Read article or submit your manuscript for publishing.

Toxoplasmosis is a zoonosis caused by an obligate intracellular parasite, Toxoplasma gondii, which affects warm-blooded animals including humans. Its prevalence rates usually vary in different regions of the planet. In this study, an analysis of the seroprevalence of toxoplasmosis among Brazilian students was proposed by means of IgG specific antibodies detection. The presence of anti-Toxoplasma gondii antibodies by indirect fluorescent antibody test (IFAT) was also evaluated in order to compare it with enzyme-linked immunosorbent assay (ELISA) and to assess the use of 2,2′-azinobis(3-ethylbenzothiazoline-6-sulfonic acid) and o-phenylenediamine dihydrochloride chromogens. The IFAT method showed a seroprevalence of 22.3%. These results were similar to those obtained by ELISA (24.1%). The seroprevalence was directly estimated from the IgG avidity, which showed that in a sample of 112 students, three of them had acute infection, an incidence of 1.6% in the studied population. In this study, the use of different chromogenic substrates in immunoenzymatic ELISA assays did not display different sensitivity in the detection of T. gondii-reagent serum. The extrapolation of results to this population must be carefully considered, since the investigation was conducted on a reduced sample. However, it allows us to emphasize the importance of careful and well prepared studies to identify risk factors for toxoplasmosis, to adopt preventive measures and to offer guidance to at-risk populations about the disease.

Foi estudada a distribuição dos enteroparasitos mais freqüentes na população de Assis, São Paulo, de 1990 a 1992. Foram analisados 18.366 exames oriundos de seis postos de atendimento sanitário (PAS): Vila Marialves, Vila Progresso, Centro, Vila Xavier, Vila Fiúza e Vila Bonfim. A prevalência de enteroparasitoses geral foi 23,3%. Os enteroparasitos mais encontrados foram: Giardia intestinalis (8,7%), Ascaris lumbricoides (5,5%), Trichuris trichiura (2,4%) e Hymenolepis nana (1,9%). Na Vila Marialves, região de baixo nível sócio-econômico essas freqüências foram, respectivamente: 17%; 13,1%; 5,9% e 4,2%. A faixa etária 3 a 12 anos apresentou maior número de indivíduos parasitados. Estabeleceu-se uma correlação entre as condições de saneamento básico, expressos pelo número de ligações de água e esgoto, e a freqüência de parasitoses. Houve queda na freqüência de parasitoses nos PAS entre 1990 e 1992, coincidindo com o aumento do número de ligações de água e esgoto nestas regiões.